BDX Becton, Dickinson and Company Common Stock
$184,65
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$128–$187
95% of range
Analystenbewertung
HOLD
21 analysts
Kursziel
$192
+4% upside
P/E (TTM)
25.3
ROE
6.5%
Nettogewinnmarge
7.7%
Über Becton, Dickinson and Company Common Stock Unternehmensübersicht von Wikipedia
BD ist eines der größten internationalen Medizintechnologie-Unternehmen. Es entwickelt, produziert und vertreibt medizinische Einmalartikel, Gerätesysteme und Reagenzien. BD versorgt Krankenhäuser, Gesundheitseinrichtungen, Biowissenschaftler, klinische Labore und die pharmazeutische Industrie. BD ist weltweit in drei Segmente gegliedert: BD Medical, BD Life Sciences und BD Interventional.
Mehr lesen
BD (Becton, Dickinson and Company) ist eines der größten internationalen Medizintechnologie-Unternehmen. Es entwickelt, produziert und vertreibt medizinische Einmalartikel, Gerätesysteme und Reagenzien. BD versorgt Krankenhäuser, Gesundheitseinrichtungen, Biowissenschaftler, klinische Labore und die pharmazeutische Industrie. BD ist weltweit in drei Segmente gegliedert: BD Medical, BD Life Sciences und BD Interventional.
Das Unternehmen ist am New York Stock Exchange und im S&P 500 Index gelistet. In der Fortune 500 Liste von 2022 belegt BD Platz 173.
Geschichte und Entwicklung
Dickinson and Company wurde 1897 von Maxwell W. Becton und Fairleigh S. Dickinson in den USA gegründet. Heute ist das Unternehmen in über 190 Ländern tätig.
Im Jahr 2014 vereinbarte BD den Erwerb des Unternehmens CareFusion und 2017 wurde das Unternehmen C. R. Bard übernommen.
Im Januar 2020 wurde Thomas Polen zum CEO und Präsident von BD und zum Nachfolger von Vincent Forlenza.
BD in Deutschland, Österreich und der Schweiz
An 10 Standorten in Deutschland, Österreich und der Schweiz beschäftigt BD mehr als 2500 Mitarbeiter.
Deutschland
2011 wurde am Standort Heidelberg das neue Gebäude eingeweiht, das nach LEED-Gold-Standard zertifiziert wurde. Das 23 Mio. Euro teure Green Building beherbergt Labore, Büro- und Seminarräume.
Österreich
In Österreich ist BD an zwei Standorten vertreten. Während am Standort Millennium Tower vorwiegend F&E für die Geschäftsbereiche Medication Management Solutions (MMS) betrieben wird, gilt der Standort Rinnböckstrasse als Standort für Vertriebstätigkeiten aller anderen Geschäftsbereiche. In Österreich sind circa 200 Personen bei BD angestellt.
Schweiz
BD ist in der Schweiz an drei Standorten vertreten. In Eysins befindet sich der europäische Hauptsitz des Unternehmens. In Allschwil sind die BD-Segmente Medical und Biosciences angesiedelt. Am Standort Wangs entwickelt und produziert die Straub Medical AG, die seit Frühjahr 2020 zu BD gehört, Medizinprodukte zur Behandlung von Durchblutungsstörungen.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
BDX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$184.65
Marktkapitalisierung
—
P/E (TTM)
25.3
EPS (TTM)
$5.82
Umsatz (TTM)
$21.84B
Dividendenrendite
—
ROE
6.5%
Verschuldungsgrad
0.7
52W-Spanne
$128 – $187
BDX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$21.84B
2016-09-30
→
2025-09-30
EPS
$5.82
2016-09-30
→
2025-09-30
Freier Cashflow
$2.67B
2016-09-30
→
2025-09-30
Margen
7.7%
2016-09-30
→
2020-09-30
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BDX
Peer-Median
P/E (TTM)
25.3
26.3
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BDX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
11.8%
—
Net Profit Margin (Nettogewinnmarge)
7.7%
15.6%
ROA
3.0%
7.6%
ROE
6.5%
15.0%
ROIC
5.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BDX
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.7
—
Current Ratio (Liquiditätsgrad)
1.1
1.7
Quick Ratio
0.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BDX
Peer-Median
Revenue YoY (Umsatz YoY)
8.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
5.0%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.3%
—
EPS YoY (EPS VjV)
-0.68%
—
Net Income YoY (Nettogewinn YoY)
-1.6%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BDX
Peer-Median
Payout Ratio (Ausschüttungsquote)
71.3%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
—
Ausschüttungsquote
71.3%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 9. Juni 2026 | $1,0500 |
| 10. März 2026 | $1,0500 |
| 8. Dezember 2025 | $0,8255 |
| 8. September 2025 | $0,8176 |
| 9. Juni 2025 | $0,8176 |
| 10. März 2025 | $0,8176 |
| 9. Dezember 2024 | $0,8176 |
| 9. September 2024 | $0,7469 |
| 10. Juni 2024 | $0,7469 |
| 7. März 2024 | $0,7469 |
| 7. Dezember 2023 | $0,7469 |
| 7. September 2023 | $0,7154 |
| 8. Juni 2023 | $0,7154 |
| 9. März 2023 | $0,7154 |
| 8. Dezember 2022 | $0,7154 |
| 8. September 2022 | $0,6840 |
| 8. Juni 2022 | $0,6840 |
| 9. März 2022 | $0,6673 |
| 9. Dezember 2021 | $0,6673 |
| 8. September 2021 | $0,6366 |
BDX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
21 Analysten
- Starker Kauf 5 23,8%
- Kauf 5 23,8%
- Halten 11 52,4%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-13
Median
$189.00
Jetzt
$184.65
Tief
$170.00
Hoch
$225.00
Median-Ziel
$189.00
+2,4%
Mittelwert-Ziel
$192.00
+4,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.08%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $3.23 | $3.17 | 0.06% |
| 31. März 2026 | $2.90 | $2.80 | 0.10% |
| 31. Dezember 2025 | $2.91 | $2.84 | 0.07% |
| 30. September 2025 | $3.96 | $3.96 | -0.00% |
| 30. Juni 2025 | $3.68 | $3.44 | 0.24% |
| 31. März 2025 | $3.35 | $3.31 | 0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B | $10.28B | $8.45B | |
| Cost of Revenue | $11.91B | $11.05B | $11.20B | $10.39B | $10.50B | $9.28B | $9.00B | $8.71B | $6.13B | $6.49B | $5.59B | $4.14B | |
| Gross Profit | · | · | · | · | · | $7.58B | $8.29B | $7.27B | $5.94B | $5.99B | $4.70B | $4.30B | |
| R&D Expense | $1.26B | $1.19B | $1.24B | $1.26B | $1.28B | $1.04B | $1.06B | $1.00B | $770M | $828M | $632M | $550M | |
| SG&A Expense | $5.28B | $4.86B | $4.72B | $4.71B | $4.72B | $4.18B | $4.33B | $4.02B | $2.91B | $3.00B | $2.56B | $2.15B | |
| Operating Expenses | $19.26B | $17.78B | $17.26B | $16.59B | $16.88B | $15.16B | $15.53B | $14.47B | $10.57B | $11.05B | $9.21B | $6.84B | |
| Operating Income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B | $912M | $1.76B | $1.51B | $1.52B | $1.43B | $1.07B | $1.61B | |
| Interest Expense | $613M | $528M | $452M | $398M | $469M | $528M | $639M | $706M | $521M | $388M | $371M | $135M | |
| Interest Income | $38M | $163M | $49M | $16M | $9M | $7M | $12M | $65M | $76M | $21M | $15M | $46M | |
| Other Non-op | $-123M | $-28M | $-46M | $-117M | $-99M | $23M | $43M | $305M | $-101M | $11M | $21M | $5M | |
| Pretax Income | $1.88B | $2.00B | $1.66B | $1.78B | $1.69B | $414M | $1.18B | $1.17B | $976M | $1.07B | $739M | $1.52B | |
| Income Tax | $203M | $300M | $132M | $148M | $88M | $62M | $-57M | $862M | $-124M | $97M | $44M | $337M | |
| Net Income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874M | $1.23B | $311M | $1.10B | $976M | $695M | $1.19B | |
| EPS (Basic) | $5.83 | $5.88 | $4.97 | $5.93 | $6.92 | $2.75 | $4.01 | $0.62 | $4.70 | $4.59 | $3.43 | $6.13 | |
| EPS (Diluted) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.94 | $0.60 | $4.60 | $4.49 | $3.35 | $5.99 | |
| Shares (Basic) | 287,648,000 | 289,763,000 | 286,282,000 | 285,005,000 | 289,288,000 | 278,971,000 | 269,943,000 | 258,354,000 | 218,943,000 | 212,702,000 | 202,537,000 | 193,299,000 | |
| Shares (Diluted) | 288,509,000 | 291,009,000 | 288,392,000 | 287,364,000 | 292,089,000 | 282,402,000 | 274,775,000 | 264,621,000 | 223,588,000 | 217,536,000 | 207,509,000 | 197,709,000 | |
| EBITDA | $5.04B | $4.68B | $4.40B | $4.51B | $5.07B | $3.64B | $4.01B | $3.48B | $2.57B | $2.54B | $1.97B | $2.17B |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $567M | $1.72B | $1.42B | $1.01B | $2.28B | $2.83B | $536M | $1.14B | $14.18B | $1.54B | $1.42B | $1.86B | |
| Receivables | $2.40B | $3.03B | $2.53B | $2.19B | $2.35B | $2.40B | $2.35B | $2.32B | $1.74B | $1.62B | $1.62B | $1.19B | |
| Inventory | $3.15B | $3.84B | $3.27B | $3.22B | $2.74B | $2.74B | $2.58B | $2.45B | $1.82B | $1.72B | $1.96B | $1.50B | |
| Other Current Assets | $1.38B | $1.29B | $1.38B | $1.56B | $1.05B | $891M | $1.12B | $1.25B | $871M | $480M | $563M | $698M | |
| Current Assets | $9.26B | $10.47B | $8.68B | $8.14B | $8.84B | $8.97B | $6.66B | $7.41B | $18.63B | $6.37B | $5.66B | $6.13B | |
| PP&E (Net) | $6.38B | $6.82B | $6.56B | $6.01B | $6.00B | $5.92B | $5.66B | $5.38B | $4.64B | $3.90B | $4.06B | $3.60B | |
| PP&E (Gross) | $13.66B | $14.38B | $13.58B | $12.41B | $12.09B | $11.92B | $11.13B | $10.48B | $9.39B | $8.42B | $8.28B | $7.76B | |
| Accum. Depreciation | $7.27B | $7.56B | $7.02B | $6.40B | $6.09B | $6.00B | $5.47B | $5.11B | $4.75B | $4.52B | $4.22B | $4.16B | |
| Goodwill | $25.96B | $26.46B | $24.52B | $24.62B | $23.89B | $23.60B | $23.38B | $23.60B | $7.56B | $7.42B | $7.54B | $1.09B | |
| Intangibles | $9.23B | $10.87B | $10.90B | $12.26B | $12.73B | $13.77B | · | · | · | · | · | · | |
| Other Non-current Assets | $2.38B | $2.62B | $2.08B | $1.85B | $1.95B | $1.69B | $1.09B | $1.08B | $1.01B | $824M | $717M | $488M | |
| Total Assets | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B | $54.01B | $51.77B | $53.90B | $37.73B | $25.59B | $26.48B | $12.38B | |
| Accounts Payable | $6.11B | $1.90B | $1.64B | $1.70B | $1.74B | $1.35B | $1.09B | $1.11B | $797M | $665M | $631M | $401M | |
| Accrued Liabilities | $3.10B | $3.48B | $2.60B | $2.60B | $2.87B | $2.64B | $2.13B | $2.25B | $1.39B | $1.57B | $1.62B | $1.05B | |
| Current Liabilities | $8.31B | $8.96B | $6.64B | $7.81B | $6.63B | $5.84B | $5.66B | $7.22B | $3.34B | $4.40B | $4.38B | $2.23B | |
| Capital Leases | $704M | $667M | $414M | $384M | $344M | $336M | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $1.95B | $130M | |
| Other Non-current Liabilities | $2.63B | $3.56B | $4.58B | $5.05B | $5.21B | $5.75B | $5.68B | $5.74B | $1.61B | $1.68B | $2.43B | $383M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $12.12B | $3.77B | |
| Total Debt | $17.62B | $17.94B | $14.74B | $13.89B | $17.11B | $17.22B | $18.08B | $18.89B | $18.67B | $10.55B | $12.12B | $3.77B | |
| Common Stock | $371M | $371M | $371M | $365M | $365M | $365M | $347M | $347M | $347M | $333M | $333M | $333M | |
| Retained Earnings | $16.62B | $16.14B | $15.54B | $15.16B | $13.83B | $12.79B | $12.91B | $12.60B | $13.11B | $12.73B | $12.31B | $12.11B | |
| Treasury Stock | $9.81B | $8.81B | $8.30B | $8.33B | $7.72B | $6.14B | $6.19B | $6.24B | $8.43B | $8.21B | $8.24B | $8.60B | |
| AOCI | $-1.90B | $-1.73B | $-1.55B | $-1.49B | $-2.09B | $-2.55B | $-2.28B | $-1.91B | $-1.72B | $-1.93B | $-1.74B | $-1.00B | |
| Stockholders' Equity | $25.39B | $25.89B | $25.80B | $25.28B | $23.68B | $23.77B | $21.08B | $20.99B | $12.95B | $7.63B | $7.16B | $5.05B | |
| Liabilities + Equity | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B | $54.01B | $51.77B | $53.90B | $37.73B | $25.59B | $26.48B | $12.45B |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.46B | $2.29B | $2.29B | $2.23B | $2.23B | $2.12B | $2.25B | $1.98B | $1.09B | $1.11B | $891M | $562M | |
| Stock-based Comp | $258M | $247M | $259M | $233M | $229M | $236M | $261M | $322M | $174M | $196M | $166M | $113M | |
| Deferred Tax | $-474M | $-211M | $-622M | $-129M | $-280M | $-285M | $-633M | $-262M | $-74M | $-519M | $-274M | $-94M | |
| Amort. of Intangibles | $1.59B | $1.47B | $1.47B | $1.43B | $1.40B | $1.38B | $1.50B | $1.25B | $553M | $552M | $346M | $84M | |
| Restructuring | $275M | $387M | $239M | $123M | $44M | $84M | · | · | $85M | $526M | $271M | · | |
| Other Non-cash | $-494M | $-183M | $-419M | $-1.64B | $333M | $553M | $216M | $516M | $262M | $792M | $252M | $-20M | |
| Operating Cash Flow | $3.43B | $3.84B | $2.99B | $2.47B | $4.13B | $2.94B | $3.33B | $2.87B | $2.55B | $2.56B | $1.73B | $1.75B | |
| CapEx | $760M | $725M | $874M | $973M | $1.19B | $769M | $957M | $895M | $727M | $693M | $596M | $592M | |
| Investing Cash Flow | $-818M | $-5.51B | $-716M | · | $-1.88B | $-1.23B | $-741M | $-15.73B | $-883M | $-669M | $-8.32B | $-948M | |
| Debt Issued | $0 | $4.52B | $1.66B | $497M | $4.87B | $3.39B | $2.22B | $5.09B | $11.46B | $0 | $6.16B | $0 | |
| Net Debt Issued | $-1.79B | $3.38B | $-493M | $-308M | $-243M | $-1.27B | $-2.52B | $1.09B | $7.48B | $-752M | $6.16B | · | |
| Stock Repurchased | $1.00B | $500M | $0 | $500M | $1.75B | $0 | $0 | $0 | $220M | $0 | $0 | $400M | |
| Net Stock Activity | $-1.00B | $-500M | $0 | $-500M | $-1.75B | · | $0 | $0 | $-220M | $0 | $0 | $-400M | |
| Dividends Paid | $1.20B | $1.10B | $1.11B | $1.08B | $1.05B | $1.03B | $984M | $927M | $677M | $562M | $485M | $421M | |
| Financing Cash Flow | $-3.62B | $2.09B | $-1.96B | · | $-3.31B | $22M | $-3.22B | $-58M | $10.98B | $-1.76B | $6.19B | $-807M | |
| Net Change in Cash | $-1.00B | $375M | $322M | $-1.23B | $-525M | $2.33B | $-646M | $-12.94B | $12.64B | $117M | $-436M | $-29M | |
| Taxes Paid | $599M | $653M | $629M | $532M | $671M | $523M | $536M | $235M | $265M | $218M | $240M | $330M | |
| Free Cash Flow | $2.67B | $3.12B | $2.12B | $1.50B | $3.42B | $2.73B | $2.37B | $1.97B | $1.82B | $1.87B | $1.13B | $1.15B | |
| Levered FCF | $2.12B | $2.67B | $1.70B | $1.13B | $2.98B | $2.26B | $1.70B | $1.78B | $1.24B | $1.51B | $785M | $1.05B |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 44.3% | 47.9% | 45.4% | 49.1% | 48.0% | 45.7% | · | |
| Operating Margin | 11.8% | 11.9% | 10.9% | 12.1% | 13.8% | 8.7% | 10.2% | 9.4% | 12.2% | 11.5% | 10.4% | 19.0% | |
| Net Margin | 7.7% | 8.5% | 7.7% | 9.4% | 10.3% | 5.1% | 7.1% | 1.9% | 9.1% | 7.8% | 6.8% | 14.0% | |
| Pretax Margin | 8.6% | 9.9% | 8.6% | 9.4% | 11.1% | 5.8% | 6.8% | 7.3% | 8.1% | 8.6% | 7.2% | 18.0% | |
| EBITDA Margin | 23.1% | 23.2% | 22.7% | 23.9% | 25.1% | 21.2% | 23.2% | 21.7% | 21.2% | 20.4% | 19.1% | 25.7% | |
| ROA | 3.0% | 3.1% | 2.8% | 3.3% | 3.9% | 1.7% | 2.3% | 0.68% | 3.5% | 3.8% | 3.5% | 9.6% | |
| ROE | 6.5% | 6.6% | 5.8% | 7.3% | 8.8% | 3.9% | 5.9% | 1.8% | 10.7% | 13.2% | 11.4% | 23.5% | |
| ROIC | 5.3% | 4.7% | 4.8% | 5.3% | 6.4% | 3.2% | 4.7% | 1.0% | 5.3% | 7.1% | 5.2% | 14.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.3 | 1.0 | 1.3 | 1.5 | 1.2 | 1.0 | 5.6 | 1.4 | 1.4 | 2.7 | |
| Quick Ratio | 0.4 | 0.5 | 0.6 | 0.4 | 0.7 | 0.9 | 0.5 | 0.5 | 4.8 | 0.7 | 0.7 | 1.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 | 0.7 | 0.9 | 0.9 | 1.4 | 1.4 | 1.7 | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 | 0.7 | 0.9 | 0.9 | 1.4 | 1.4 | 1.6 | 0.7 | |
| Interest Coverage | 4.2 | 4.5 | 4.7 | 5.7 | 6.0 | 2.8 | 2.8 | 2.1 | 2.8 | 3.7 | 2.9 | 11.9 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | |
| Inventory Turnover | 3.1 | 3.1 | 3.4 | 3.5 | 3.9 | 3.6 | 3.6 | 4.1 | 3.5 | 3.5 | 3.2 | 2.9 | |
| Receivables Turnover | 7.2 | 7.2 | 8.2 | 8.3 | 8.3 | 7.2 | 7.4 | 7.9 | 7.2 | 7.7 | 7.3 | 7.0 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.2% | 4.2% | 2.7% | -1.4% | 19.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.0% | 1.8% | 6.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -0.68% | 18.6% | -16.0% | -14.2% | 152.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.34% | -5.1% | 22.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | 14.9% | -16.6% | -15.0% | 139.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.9% | -6.6% | 19.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 13.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.1% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B | $10.28B | $8.45B | |
| Net Income TTM | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874M | $1.23B | $311M | $1.10B | $976M | $695M | $1.19B | |
| P/E | 25.3 | 32.3 | 41.1 | 29.8 | 27.5 | 65.9 | 49.2 | 333.6 | 32.7 | 30.7 | 30.4 | 14.6 | |
| Earnings Yield | 4.0% | 3.1% | 2.4% | 3.4% | 3.6% | 1.5% | 2.0% | 0.30% | 3.1% | 3.3% | 3.3% | 6.9% | |
| Payout Ratio | 71.3% | 64.5% | 75.1% | 60.8% | 50.1% | 117.4% | 79.8% | 298.1% | 61.6% | 57.6% | 69.8% | 35.5% | |
| Annual Payout | $1.20B | $1.10B | $1.11B | $1.08B | $1.05B | $1.03B | $984M | $927M | $677M | $562M | $485M | $421M |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.98B | $4.71B | $5.25B | $5.89B | $4.73B | $4.48B | $5.17B | $5.44B | $4.99B | $5.04B | $4.71B | $5.09B | $4.88B | $4.82B | $4.59B | $4.76B | |
| Cost of Revenue | $2.67B | $2.56B | $2.84B | $3.09B | $2.49B | $2.62B | $2.93B | $2.95B | $2.68B | $2.74B | $2.68B | $3.38B | $2.78B | $2.59B | $2.45B | $2.68B | |
| R&D Expense | $258M | $249M | $306M | $323M | $230M | $232M | $343M | $302M | $299M | $299M | $290M | $281M | $306M | $337M | $313M | $300M | |
| SG&A Expense | $1.26B | $1.21B | $1.39B | $1.37B | $1.16B | $1.12B | $1.32B | $1.25B | $1.20B | $1.19B | $1.21B | $1.14B | $1.19B | $1.21B | $1.19B | $1.18B | |
| Operating Expenses | $4.32B | $4.62B | $4.70B | $5.19B | $3.99B | $4.10B | $4.71B | $4.81B | $4.39B | $4.31B | $4.27B | $4.74B | $4.33B | $4.19B | $4.00B | $4.27B | |
| Operating Income | $663M | $93M | $552M | $698M | $739M | $383M | $453M | $622M | $602M | $734M | $439M | $349M | $549M | $628M | $585M | $489M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $125M | $111M | $113M | $119M | $118M | $102M | $104M | |
| Interest Income | $4M | $9M | $4M | $5M | $4M | $5M | $23M | $55M | $48M | $26M | $34M | $9M | $24M | $10M | $6M | $7M | |
| Other Non-op | $19M | $86M | $-10M | $-36M | $-22M | $-36M | $-16M | $-9M | $-13M | $-2M | $-4M | $-63M | $17M | $8M | $-8M | $-73M | |
| Pretax Income | $554M | $39M | $393M | $509M | $569M | $201M | $306M | $513M | $500M | $633M | $359M | $181M | $471M | $529M | $481M | $320M | |
| Income Tax | $102M | $76M | $11M | $16M | $118M | $43M | $3M | $114M | $13M | $96M | $77M | $28M | $64M | $68M | $-28M | $33M | |
| Net Income | $377M | $-311M | $382M | $493M | $574M | $308M | $303M | $400M | $487M | $537M | $281M | $108M | $407M | $460M | $509M | $288M | |
| EPS (Basic) | $1.37 | $-1.11 | $1.34 | $1.71 | $2.00 | $1.07 | $1.05 | $1.38 | $1.68 | $1.85 | $0.97 | $0.35 | $1.37 | $1.54 | $1.71 | $0.94 | |
| EPS (Diluted) | $1.37 | $-1.11 | $1.34 | $1.71 | $2.00 | $1.07 | $1.04 | $1.37 | $1.68 | $1.85 | $0.96 | $0.35 | $1.36 | $1.53 | $1.70 | $0.92 | |
| Shares (Basic) | 274,788,000 | 280,640,000 | 285,582,000 | -576,320,000 | 287,170,000 | 287,293,000 | 289,505,000 | -579,430,000 | 289,562,000 | 289,518,000 | 290,113,000 | -568,214,000 | 286,317,000 | 284,292,000 | 283,887,000 | -570,364,000 | |
| Shares (Diluted) | 275,158,000 | 280,640,000 | 285,845,000 | -576,840,000 | 287,223,000 | 287,737,000 | 290,389,000 | -580,986,000 | 290,253,000 | 290,344,000 | 291,398,000 | -570,537,000 | 287,944,000 | 285,645,000 | 285,340,000 | -573,955,000 | |
| EBITDA | $1.23B | $656M | $1.17B | · | $882M | $546M | $1.06B | · | $602M | $734M | $1.00B | · | $549M | $628M | $1.15B | · |
Bilanz 24
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $708M | $813M | $740M | $641M | $735M | $667M | $711M | $1.72B | $4.46B | $2.35B | $1.18B | · | $923M | $1.98B | $612M | · | |
| Receivables | $2.36B | $2.21B | $2.51B | $2.99B | $2.94B | $3.03B | $2.64B | $3.03B | $2.60B | $2.56B | $2.27B | · | $2.41B | $2.41B | $2.28B | · | |
| Inventory | $3.32B | $3.36B | $4.08B | $3.89B | $3.95B | $3.72B | $3.86B | $3.84B | $3.25B | $3.23B | $3.30B | · | $3.59B | $3.66B | $3.60B | · | |
| Other Current Assets | $1.59B | $1.43B | $1.56B | $1.51B | $1.28B | $1.15B | $1.33B | $1.29B | $1.02B | $1.33B | $1.35B | · | $1.28B | $1.44B | $1.54B | · | |
| Current Assets | $8.14B | $8.01B | $9.19B | $9.26B | $9.00B | $8.67B | $8.66B | $10.47B | $12.21B | $10.34B | $8.16B | · | $8.59B | $9.59B | $8.18B | · | |
| PP&E (Net) | $6.08B | $6.08B | $6.97B | $7.00B | $6.82B | $6.65B | $6.60B | $6.82B | $6.52B | $6.59B | $6.65B | · | $6.47B | $6.36B | $6.25B | · | |
| PP&E (Gross) | $13.60B | $13.55B | $15.24B | $15.11B | $14.85B | $14.41B | $14.16B | $14.38B | $13.92B | $13.93B | $13.90B | · | $13.47B | $13.20B | $12.93B | · | |
| Accum. Depreciation | $7.52B | $7.47B | $8.27B | $8.12B | $8.04B | $7.76B | $7.55B | $7.56B | $7.40B | $7.33B | $7.25B | · | $7.00B | $6.85B | $6.68B | · | |
| Goodwill | $25.94B | $25.95B | $26.62B | $26.61B | $26.60B | $26.44B | $26.33B | $26.46B | $24.55B | $24.57B | $24.60B | $24.52B | $24.58B | $24.78B | $24.76B | $24.62B | |
| Intangibles | $8.02B | $8.35B | $9.01B | $9.39B | $9.77B | $10.12B | $10.47B | $10.87B | $9.86B | $10.21B | $10.57B | · | $11.27B | $11.63B | $11.94B | · | |
| Other Non-current Assets | $2.55B | $2.43B | $3.04B | $3.06B | $2.70B | $2.58B | $2.59B | $2.62B | $2.40B | $2.40B | $2.26B | · | $2.06B | $1.99B | $1.96B | · | |
| Total Assets | $50.73B | $50.83B | $54.84B | $55.33B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B | $52.27B | · | $53.02B | $54.39B | $53.13B | · | |
| Accounts Payable | $6.11B | $5.93B | $6.14B | $1.97B | $6.35B | $6.09B | $6.35B | $1.90B | $5.41B | $5.31B | $5.52B | · | $5.02B | $5.09B | $5.44B | · | |
| Accrued Liabilities | · | · | · | $3.10B | · | · | · | $3.48B | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9.40B | $8.51B | $8.76B | $8.31B | $8.16B | $7.69B | $7.66B | $8.96B | $6.61B | $7.33B | $7.54B | · | $6.88B | $7.30B | $7.62B | · | |
| Capital Leases | · | · | · | $704M | · | · | · | $667M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.39B | $2.46B | $2.81B | $2.93B | $2.83B | $3.00B | $3.42B | $3.56B | $4.07B | $4.30B | $4.41B | · | $4.37B | $4.47B | $4.86B | · | |
| Total Debt | $13.51B | $14.71B | $16.92B | · | $17.53B | $17.67B | $17.44B | · | $18.13B | $15.99B | $14.09B | · | $14.93B | $16.01B | $14.27B | · | |
| Common Stock | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | · | $371M | $365M | $365M | · | |
| Retained Earnings | $17.51B | $17.39B | $16.70B | $16.62B | $16.43B | $16.15B | $16.14B | $16.14B | $16.02B | $15.80B | $15.54B | · | $15.69B | $15.56B | $15.38B | · | |
| Treasury Stock | $12.06B | $11.66B | $10.06B | $9.81B | $9.56B | $9.56B | $9.43B | $8.81B | $8.81B | $8.81B | $8.83B | · | $8.32B | $8.33B | $8.33B | · | |
| AOCI | $-1.65B | $-1.76B | $-1.86B | $-1.90B | $-1.81B | $-1.72B | $-1.68B | $-1.73B | $-1.58B | $-1.53B | $-1.51B | · | $-1.51B | $-1.57B | $-1.56B | $-1.49B | |
| Stockholders' Equity | $24.42B | $24.13B | $25.28B | $25.39B | $25.47B | $25.24B | $25.20B | $25.89B | $25.87B | $25.65B | $25.33B | · | $25.94B | $25.69B | $25.47B | · | |
| Liabilities + Equity | $50.73B | $50.83B | $54.84B | $55.33B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B | $52.27B | · | $53.02B | $54.39B | $53.13B | · |
Cashflow 16
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $564M | $563M | $614M | $629M | $575M | $567M | $607M | $586M | $568M | $571M | $561M | $587M | $571M | $563M | $567M | $581M | |
| Stock-based Comp | $55M | $58M | $91M | $55M | $54M | $59M | $90M | $51M | $53M | $60M | $83M | $58M | $56M | $56M | $89M | $49M | |
| Amort. of Intangibles | $365M | $380M | $397M | $398M | $388M | $387M | $395M | $375M | $362M | $366M | $365M | $367M | $367M | $366M | $365M | $366M | |
| Restructuring | $48M | $482M | $75M | $88M | $58M | $63M | $66M | $125M | $95M | $98M | $69M | $119M | $61M | $33M | $26M | $51M | |
| Other Non-cash | · | · | $-845M | · | · | · | $-677M | · | · | · | $82M | · | · | · | $-1.43B | · | |
| Operating Cash Flow | $776M | $671M | $657M | $1.35B | $1.22B | $164M | $693M | $1.18B | $1.30B | $514M | $855M | $1.32B | $1.08B | $185M | $399M | $973M | |
| CapEx | $143M | $125M | $108M | $352M | $174M | $129M | $105M | $296M | $179M | $134M | $116M | $294M | $191M | $181M | $208M | $315M | |
| Investing Cash Flow | · | · | $-183M | $-494M | $-336M | $-192M | $204M | $-3.94B | $-288M | $-1.06B | $-233M | $137M | $-329M | $-233M | $-291M | · | |
| Net Debt Issued | $-2.00B | $-2.00B | $0 | · | · | · | $-875M | · | · | · | $0 | · | · | · | $-528M | · | |
| Stock Repurchased | $0 | $2.00B | $250M | $250M | $0 | $0 | $750M | $0 | $0 | $0 | $500M | $0 | $0 | $0 | $0 | $500M | |
| Net Stock Activity | · | · | $-250M | · | · | · | $-750M | · | · | · | $-500M | · | · | · | · | · | |
| Dividends Paid | $286M | $290M | $299M | $297M | $299M | $298M | $302M | $275M | $275M | $275M | $275M | $265M | $286M | $282M | $281M | $270M | |
| Financing Cash Flow | · | · | $-302M | $-809M | $-841M | $-39M | $-1.93B | $124M | $1.12B | $1.71B | $-862M | $-997M | $-1.79B | $1.37B | $-534M | · | |
| Net Change in Cash | $-152M | $64M | $174M | $53M | $51M | $-66M | $-1.04B | $-2.63B | $2.09B | $1.16B | $-247M | $456M | $-1.04B | $1.32B | $-415M | $-1.60B | |
| Free Cash Flow | · | · | $549M | · | · | · | $588M | · | · | · | $739M | · | · | · | $191M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $652M | · | · | · | $83M | · |
Rentabilität 7
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.3% | 2.0% | 10.5% | · | 16.0% | 10.4% | 8.8% | · | 12.1% | 14.5% | 9.3% | · | 11.2% | 13.0% | 12.8% | · | |
| Net Margin | 7.6% | -6.6% | 7.3% | · | 10.4% | 5.8% | 5.9% | · | 9.8% | 10.6% | 6.0% | · | 8.3% | 9.5% | 11.1% | · | |
| Pretax Margin | 11.1% | 0.83% | 7.5% | · | 12.8% | 6.9% | 5.9% | · | 10.0% | 12.6% | 7.6% | · | 9.7% | 11.0% | 10.5% | · | |
| EBITDA Margin | 24.6% | 13.9% | 22.2% | · | 16.0% | 10.4% | 20.5% | · | 12.1% | 14.5% | 21.2% | · | 11.2% | 13.0% | 25.1% | · | |
| ROA | 0.71% | -0.59% | 0.70% | · | 1.0% | 0.57% | 0.57% | · | 0.90% | 0.99% | 0.53% | · | 0.77% | 0.84% | 0.96% | · | |
| ROE | 1.5% | -1.3% | 1.5% | · | 2.2% | 1.2% | 1.2% | · | 1.9% | 2.1% | 1.1% | · | 1.6% | 1.8% | 2.1% | · | |
| ROIC | 1.4% | -0.23% | 1.3% | · | 1.7% | 1.1% | 1.1% | · | 1.3% | 1.5% | 0.87% | · | 1.2% | 1.3% | 1.6% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.1 | 1.1 | · | 1.8 | 1.4 | 1.1 | · | 1.2 | 1.3 | 1.1 | · | |
| Quick Ratio | 0.3 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 1.1 | 0.7 | 0.5 | · | 0.5 | 0.6 | 0.4 | · | |
| Debt / Equity | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | |
| LT Debt / Equity | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.9 | 4.0 | · | 4.6 | 5.3 | 5.7 | · |
Effizienz 3
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | |
| Receivables Turnover | 1.9 | 1.8 | 2.0 | · | 2.0 | 1.9 | 2.1 | · | 2.0 | 2.0 | 2.1 | · | 2.1 | 2.0 | 2.1 | · |
Bewertung (TTM) 5
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19.68B | $19.95B | $21.20B | · | $20.94B | $20.48B | $19.91B | · | $19.62B | $19.45B | $18.99B | · | $18.93B | $18.80B | $18.70B | · | |
| Net Income TTM | $1.02B | $953M | $1.57B | · | $1.67B | $1.64B | $1.61B | · | $1.71B | $1.69B | $1.66B | · | $1.74B | $1.78B | $2.00B | · | |
| P/E | 42.0 | 47.6 | 28.0 | · | 23.4 | 31.9 | 32.3 | · | 31.4 | 34.1 | 34.5 | · | 36.0 | 32.9 | 30.0 | · | |
| Earnings Yield | 2.4% | 2.1% | 3.6% | · | 4.3% | 3.1% | 3.1% | · | 3.2% | 2.9% | 2.9% | · | 2.8% | 3.0% | 3.3% | · | |
| Payout Ratio | · | · | 78.3% | · | · | · | 99.7% | · | · | · | 97.9% | · | · | · | 55.2% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Umsatz | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B |
| Betriebsgewinnmarge % | 11.8% | 11.9% | 10.9% | 12.1% | 13.8% |
| Nettoergebnis | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B |
| Verwässerte EPS | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
Bilanz
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 |
| Liquiditätsgrad | 1.1 | 1.2 | 1.3 | 1.0 | 1.3 |
| Quick Ratio | 0.4 | 0.5 | 0.6 | 0.4 | 0.7 |
Cashflow
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $2.67B | $3.12B | $2.12B | $1.50B | $3.42B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait”
- Ist die Wall Street gegenüber der Becton, Dickinson and Company Aktie bullisch oder bärisch?
- Becton Dickinson (BDX) liefert solide Q2-Leistung, Barclays hebt Ziel an
- Jim Cramer über Becton, Dickinson: „Das Unternehmen zeigte durchweg eine ausgezeichnete Leistung“
- Becton, Dickinson and Company Q2 Earnings Call Highlights
- RBC kürzt die Prognose für Becton Dickinson (BDX) trotz stabiler MedTech-Nachfrage
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.566 Einreicher · $23.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 132 (-14 vs. Vorquartal) | 139 (-44 vs. Vorquartal) | 528 (-21 vs. Vorquartal) | 517 (-18 vs. Vorquartal) | +42.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.722.098.919 | 17.987.834 | 11,82% | Aktien |
| STATE STREET CORP | $2.269.959.685 | 15.000.064 | 9,86% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.266.036.001 | 14.974.136 | 9,84% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.091.146.340 | 7.234.861 | 4,74% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $932.773.605 | 6.163.838 | 4,05% | Aktien |
| GREENHAVEN ASSOCIATES INC | $859.812.872 | 5.681.708 | 3,73% | Aktien |
| NORGES BANK | $630.973.916 | 4.169.523 | 2,74% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $556.370.023 | 3.676.534 | 2,42% | Aktien |
| Clearbridge Investments, LLC | $486.953.464 | 3.217.825 | 2,11% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $385.001.377 | 2.544.118 | 1,67% | Aktien |
| HARRIS ASSOCIATES L P | $355.771.231 | 2.350.963 | 1,54% | Aktien |
| First Pacific Advisors, LP | $319.426.456 | 2.110.794 | 1,39% | Aktien |
| Longview Partners (Guernsey) LTD | $255.761.774 | 1.690.093 | 1,11% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $246.946.383 | 1.631.842 | 1,07% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $234.270.795 | 1.548.079 | 1,02% | Aktien |
| MACKENZIE FINANCIAL CORP | $216.917.330 | 1.433.406 | 0,94% | Aktien |
| Veritas Asset Management LLP | $210.852.478 | 1.393.329 | 0,92% | Aktien |
| JARISLOWSKY, FRASER Ltd | $175.028.282 | 935.130 | 0,76% | Aktien |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $167.650.789 | 1.107.849 | 0,73% | Aktien |
| ProShare Advisors LLC | $162.283.113 | 1.072.379 | 0,70% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $156.784.054 | 1.036.041 | 0,68% | Aktien |
| Focus Partners Wealth | $144.422.511 | 954.318 | 0,63% | Aktien |
| Findlay Park Partners LLP | $143.945.096 | 951.200 | 0,63% | Aktien |
| COOKE & BIELER LP | $140.226.313 | 926.626 | 0,61% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $135.204.343 | 893.440 | 0,59% | Aktien |
| M&G PLC | $134.044.663 | 887.713 | 0,58% | Aktien |
| FIDUCIARY MANAGEMENT INC /WI/ | $125.873.419 | 831.781 | 0,55% | Aktien |
| Cullen Capital Management, LLC | $124.804.866 | 824.720 | 0,54% | Aktien |
| Swiss National Bank | $121.639.357 | 803.802 | 0,53% | Aktien |
| BANK OF AMERICA CORP /DE/ | $109.436.862 | 723.167 | 0,48% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $107.392.091 | 709.655 | 0,47% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $106.856.080 | 706.113 | 0,46% | Aktien |
| GOLDMAN SACHS GROUP INC | $106.367.473 | 702.884 | 0,46% | Aktien |
| Liontrust Investment Partners LLP | $106.174.921 | 547.096 | 0,46% | Aktien |
| Legal & General Group Plc | $105.651.343 | 698.152 | 0,46% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $105.208.376 | 496.758 | 0,46% | Aktien |
| VANGUARD GROUP INC | $102.900.766 | 530.225 | 0,45% | Aktien |
| BARCLAYS PLC | $97.089.091 | 641.572 | 0,42% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $96.682.770 | 638.887 | 0,42% | Aktien |
| DAVENPORT & Co LLC | $95.832.076 | 628.589 | 0,42% | Aktien |
| Vanguard Global Advisers, LLC | $91.460.069 | 604.375 | 0,40% | Aktien |
| BlackRock, Inc. | $90.571.308 | 598.502 | 0,39% | Aktien |
| National Pension Service | $90.290.591 | 596.647 | 0,39% | Aktien |
| 1832 Asset Management L.P. | $89.099.472 | 588.776 | 0,39% | Aktien |
| EVERETT HARRIS & CO /CA/ | $84.132.408 | 555.953 | 0,37% | Aktien |
| California Public Employees Retirement System | $82.720.459 | 546.623 | 0,36% | Aktien |
| NOMURA ASSET MANAGEMENT CO LTD | $81.543.868 | 538.848 | 0,35% | Aktien |
| STOREBRAND ASSET MANAGEMENT AS | $76.741.410 | 507.113 | 0,33% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $74.425.607 | 473.355 | 0,32% | Aktien |
| RHUMBLINE ADVISERS | $69.490.510 | 459.199 | 0,30% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $69.072.023 | 458.250 | 0,30% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $68.065.813 | 449.784 | 0,30% | Aktien |
| JANUS HENDERSON GROUP PLC | $67.523.210 | 429.455 | 0,29% | Aktien |
| ASSETMARK, INC | $66.195.056 | 437.422 | 0,29% | Aktien |
| PRUDENTIAL FINANCIAL INC | $65.722.619 | 434.300 | 0,29% | Aktien |
| LPL Financial LLC | $62.882.601 | 415.533 | 0,27% | Aktien |
| River Road Asset Management, LLC | $62.597.806 | 413.651 | 0,27% | Aktien |
| Gotham Asset Management, LLC | $56.207.745 | 371.425 | 0,24% | Aktien |
| AMERIPRISE FINANCIAL INC | $55.861.167 | 369.130 | 0,24% | Aktien |
| Nuveen Asset Management, LLC | $51.685.297 | 227.819 | 0,22% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $51.666.564 | 328.605 | 0,22% | Aktien |
| EXCHANGE TRADED CONCEPTS, LLC | $48.832.980 | 322.692 | 0,21% | Aktien |
| JANE STREET GROUP, LLC | $48.501.265 | 320.500 | 0,21% | Kaufoption |
| Balyasny Asset Management L.P. | $47.987.802 | 317.107 | 0,21% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $46.772.834 | 309.078 | 0,20% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $46.640.815 | 308.206 | 0,20% | Aktien |
| Vest Financial, LLC | $46.231.769 | 305.503 | 0,20% | Aktien |
| James Hambro & Partners LLP | $44.732.855 | 295.686 | 0,19% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $44.466.656 | 293.839 | 0,19% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $43.163.402 | 285.227 | 0,19% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $42.589.065 | 280.319 | 0,18% | Aktien |
| FMR LLC | $42.291.821 | 279.467 | 0,18% | Aktien |
| First Eagle Investment Management, LLC | $41.653.917 | 275.252 | 0,18% | Aktien |
| Invenomic Capital Management LP | $41.340.632 | 273.182 | 0,18% | Aktien |
| ZACKS INVESTMENT MANAGEMENT | $39.662.458 | 262.091 | 0,17% | Aktien |
| AMI ASSET MANAGEMENT CORP | $38.930.771 | 257.257 | 0,17% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $38.536.481 | 254.652 | 0,17% | Aktien |
| Squarepoint Ops LLC | $38.359.885 | 253.485 | 0,17% | Aktien |
| STRS OHIO | $38.341.877 | 253.366 | 0,17% | Aktien |
| 683 Capital Management, LLC | $37.832.500 | 250.000 | 0,16% | Aktien |
| Eurizon Capital SGR S.p.A. | $36.515.647 | 241.235 | 0,16% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $36.203.433 | 239.235 | 0,16% | Aktien |
| AVIVA PLC | $36.174.680 | 239.045 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35.441.486 | 234.200 | 0,15% | Kaufoption |
| Mawer Investment Management Ltd. | $35.092.670 | 231.895 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $33.882.787 | 223.900 | 0,15% | Verkaufsoption |
| TD Asset Management Inc | $32.957.404 | 217.785 | 0,14% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $32.502.506 | 214.779 | 0,14% | Aktien |
| UBS Group AG | $32.325.753 | 213.611 | 0,14% | Aktien |
| BANK OF MONTREAL /CAN/ | $30.124.355 | 199.064 | 0,13% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $29.442.037 | 193.609 | 0,13% | Aktien |
| KLP KAPITALFORVALTNING AS | $29.188.531 | 192.880 | 0,13% | Aktien |
| Swedbank AB | $28.764.201 | 190.076 | 0,12% | Aktien |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $28.737.567 | 189.900 | 0,12% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $28.516.700 | 182.893 | 0,12% | Aktien |
| Cerity Partners LLC | $27.848.462 | 184.026 | 0,12% | Aktien |
| CACTI ASSET MANAGEMENT LLC | $27.284.194 | 180.296 | 0,12% | Aktien |
| Cardinal Capital Management, Inc. | $26.317.472 | 167.382 | 0,11% | Aktien |
| APG Asset Management N.V. | $26.264.286 | 198.427 | 0,11% | Aktien |
| Quantinno Capital Management LP | $26.164.445 | 172.896 | 0,11% | Aktien |
Unternehmensinsider 66 Insider · 19 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopher Delorefice | EVP & Chief Financial Officer | 1. September 2025 F | 21.221 | 0 | 0 | $0 |
| Michael Feld | EVP, Chief Revenue Officer | 27. Juli 2026 S | 20.934 | 0 | 4 | $-45.581 |
| Bilal Muhsin | EVP & President Connected Care | 2. Juli 2026 F | 41.359 | 0 | 0 | $0 |
| Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | 24. Juni 2026 S | 13.172 | 0 | 2 | $-326.854 |
| Peter Menziuso | EVP and President, BDI | 1. Juni 2026 A | 14.258 | 0 | 0 | $0 |
| Richard Byrd | EVP & President Interventional | 1. September 2025 F | 6.736 | 0 | 0 | $0 |
| David Shan | EVP and Chief ISC Officer | 2. Juni 2025 S | 4.575 | 0 | 0 | $0 |
| Shana Carol Neal | EVP and Chief People Officer | 4. April 2025 F | 13.528 | 0 | 0 | $0 |
| Michelle Quinn | EVP and General Counsel | 26. November 2024 A | 6.927 | 0 | 0 | $0 |
| Pavan Kumar Mocherla | EVP & President, Greater Asia | 26. November 2024 F | 2.847 | 0 | 0 | $0 |
| Antoine C Ezell | EVP, President Americas & CMO | 26. November 2024 A | 11.970 | 0 | 0 | $0 |
| Thomas J Spoerel | SVPController & Chief Acct Off | 1. Juli 2024 F | 1.928 | 0 | 0 | $0 |
| David Hickey | EVP & President, Life Sciences | 26. November 2023 A | 5.862 | 0 | 0 | $0 |
| Samrat S. Khichi | EVP and General Counsel | 21. Dezember 2022 G | 9.251 | 0 | 0 | $0 |
| Rishi Grover | EVP and Chief ISC Officer | 8. Juli 2022 A | 9.439 | 0 | 0 | $0 |
| James Lim | Executive Vice President | 17. Juni 2022 A | 23.941 | 0 | 0 | $0 |
| Betty D Larson | EVP HR & CHRO | 25. Februar 2022 M | 5.872 | 0 | 0 | $0 |
| Simon D Campion | EVP and Segment President | 11. Februar 2022 G | 10.319 | 0 | 0 | $0 |
| Alexandre Conroy | EVP of Integrated Supply Chain | 3. Februar 2022 M | 21.260 | 0 | 0 | $0 |
| Gregory Hayes | Direktor | 11. August 2025 P | 6.046 | 0 | 0 | $0 |
| Christopher Ian Montague Jones | Direktor | 7. August 2025 A | 22.701 | 0 | 0 | $0 |
| Bertram L Scott | Direktor | 12. Februar 2025 S | 36.033 | 0 | 0 | $0 |
| Jeffrey William Henderson | Direktor | 10. Februar 2025 P | 8.015 | 0 | 0 | $0 |
| Joanne Waldstreicher | Direktor | 28. Januar 2025 A | 2.270 | 0 | 0 | $0 |
| William M Brown | Direktor | 28. Januar 2025 A | 3.486 | 0 | 0 | $0 |
| Catherine M Burzik | Direktor | 28. Januar 2025 A | 14.264 | 0 | 0 | $0 |
| Andrew R Eckert | Direktor | 28. Januar 2025 A | 9.170 | 0 | 0 | $0 |
| Timothy M Ring | Direktor | 28. Januar 2025 A | 57.915 | 0 | 0 | $0 |
| LARSEN MARSHALL O | Direktor | 24. Januar 2023 A | 28.919 | 0 | 0 | $0 |
| Claire Pomeroy | Direktor | 25. Januar 2022 A | 9.982 | 0 | 0 | $0 |
| David F Melcher | Direktor | 25. Januar 2022 A | 6.180 | 0 | 0 | $0 |
| BECTON DICKINSON & CO | 10%-Eigentümer | 9. Februar 2026 J | 0 | 0 | 0 | $0 |
| Thomas E Polen Jr | — | 13. August 2026 M | 110.163 | 0 | 2 | $-1.172.631 |
| Roland Goette | — | 11. August 2026 S | 14.856 | 0 | 1 | $-440.888 |
| Carrie L Byington | — | 6. August 2026 A | 3.834 | 0 | 0 | $0 |
| Robert Luther Huffines | — | 6. August 2026 A | — | 0 | 0 | $0 |
| Claire Fraser | — | 10. September 2025 S | 22.226 | 0 | 1 | $-171.938 |
| Alfred Sommer | — | 8. August 2012 M | 16.228 | 0 | 0 | $0 |
| Jeffrey S Sherman | — | 3. August 2012 M | 20.908 | 0 | 0 | $0 |
| Edward J Ludwig | — | 27. Februar 2012 S | 97.188 | 0 | 0 | $0 |
| Donna M Boles | — | 17. Februar 2012 S | 12.490 | 0 | 0 | $0 |
| Wilard J Overlock JR | — | 13. Februar 2012 M | 26.037 | 0 | 0 | $0 |
| Henry P Becton JR | — | 13. Februar 2012 M | 125.357 | 0 | 0 | $0 |
| Gary A Mecklenburg | — | 31. Januar 2012 A | 14.873 | 0 | 0 | $0 |
| Edward Degraan | — | 31. Januar 2012 A | 16.228 | 0 | 0 | $0 |
| James F Orr | — | 31. Januar 2012 A | 17.228 | 0 | 0 | $0 |
| Adel Mahmoud | — | 31. Januar 2012 A | 11.479 | 0 | 0 | $0 |
| Basil Anderson | — | 31. Januar 2012 A | 14.873 | 0 | 0 | $0 |
| Gary M Cohen | — | 15. Dezember 2011 S | 66.902 | 0 | 0 | $0 |
| David V Elkins | — | 2. Dezember 2011 I | 9.115 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter | 8. September 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 1. September 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 25. August 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 16. August 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 14. August 2006 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 193 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 4,95% | 935.403 SH | 8. August 2026 | Täglich |
| LBAY · Tidal Trust I | 3,45% | 4.137 NS | 31. Mai 2026 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3,32% | 13.719 NS | 31. Mai 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 3,23% | 284.107 NS | 30. April 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 3,18% | 76.266 NS | 31. Mai 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 2,27% | 24.656 SH | 8. August 2026 | Täglich |
| FEGE · RBB Fund Trust | 2,07% | 272.648 NS | 31. Mai 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,81% | 80.145 SH | 8. August 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,64% | 96.279 NS | 30. April 2026 | N-PORT |
| EPOL · iShares Trust | 1,59% | 65.559 SH | 8. August 2026 | Täglich |
| ANEW · ProShares Trust | 1,53% | 802 NS | 31. Mai 2026 | N-PORT |
| TMDV · ProShares Trust | 1,39% | 416 NS | 31. Mai 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,38% | 312.905 NS | 30. April 2026 | N-PORT |
| NOBL · ProShares Trust | 1,38% | 1.035.312 NS | 31. Mai 2026 | N-PORT |
| SWP · Manager Directed Portfolios | 1,05% | 11.025 NS | 31. Mai 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 1,02% | 2.358 NS | 31. Mai 2026 | N-PORT |
| IYH · iShares Trust | 0,82% | 170.236 SH | 8. August 2026 | Täglich |
| ITAN · EA Series Trust | 0,75% | 4.537 NS | 29. Mai 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,72% | 1.769.988 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,69% | 131.388 NS | 30. April 2026 | N-PORT |
| RGEF · Tidal Trust III | 0,68% | 36.445 NS | 30. April 2026 | N-PORT |
| IMCV · iShares Trust | 0,68% | 44.111 SH | 8. August 2026 | Täglich |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,66% | 57.591 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,64% | 856.811 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,62% | 144.713 SH | 8. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,61% | 5.676 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,61% | 2.969 NS | 31. Mai 2026 | N-PORT |
| SNPD · DBX ETF Trust | 0,59% | 105 NS | 29. Mai 2026 | N-PORT |
| IWS · iShares Trust | 0,48% | 428.905 SH | 8. August 2026 | Täglich |
| DIVB · iShares Trust | 0,41% | 40.828 SH | 8. August 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,40% | 5.971.067 SH | 8. August 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,39% | 17.824.000 | 8. August 2026 | Täglich |
| FDLO · FIDELITY COVINGTON TRUST | 0,38% | 36.058 NS | 30. April 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,37% | 10.309 SH | 8. August 2026 | Täglich |
| VLUE · iShares Trust | 0,36% | 193.512 SH | 8. August 2026 | Täglich |
| IWR · iShares Trust | 0,36% | 1.157.380 SH | 8. August 2026 | Täglich |
| HUSV · First Trust Exchange-Traded Fund III | 0,36% | 1.753 NS | 30. April 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,34% | 9.312 NS | 31. Mai 2026 | N-PORT |
| IMCB · iShares Trust | 0,33% | 31.709 SH | 8. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,33% | 18.654 SH | 8. August 2026 | Täglich |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,33% | 3.038 NS | 30. April 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,31% | 31.254 NS | 30. April 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,30% | 3.445 NS | 30. April 2026 | N-PORT |
| DGRO · iShares Trust | 0,29% | 712.491 SH | 8. August 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,28% | 110.352 NS | 30. April 2026 | N-PORT |
| XOEF · iShares Trust | 0,27% | 347 SH | 8. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 1.255.749 SH | 8. August 2026 | Täglich |
| SIZE · iShares Trust | 0,22% | 5.332 SH | 8. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,21% | 23.094 SH | 8. August 2026 | Täglich |
| CAPE · DoubleLine ETF Trust | 0,21% | 3.525 NS | 31. März 2026 | N-PORT |